Why does Agios Pharmaceuticals stock have such a negative reputation?
Agios Pharma, a biotech company focused on developing and commercializing new drugs for the treatment of Parkinson’s disease and Alzheimer’s, is on the upswing with a $3 billion valuation.The stock rose 3.6% after reports that the company was in talks to acquire another drugmaker, a move that would give the pharmaceutical company an even bigger…